Alaunos Therapeutics, Inc.
USD2.62
-0.13 (-4.73%)
CEO
Holger Weis
IPO Date
2005-08-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.77
Prev. Close
$2.75
Day Low
$2.61
Day High
$2.77
52W Low
$1.67
52W High
$6.20
Market Cap
$0.01B
Volume
0.01M
| 6,515 |
| $2.59 |
| 1 May 2026 | Postma Robert W | director | A-Award | Acquired | 6,274 | $2.59 |
| 1 May 2026 | Jerman Michael Allen | director | A-Award | Acquired | 6,032 | $2.59 |
| 15 Jan 2026 | Jerman Michael Allen | director | A-Award | Acquired | 5,406 | $2.89 |
| 15 Jan 2026 | Postma Robert W | director | A-Award | Acquired | 5,622 | $2.89 |
| 15 Jan 2026 | Vieser Jaime | director | A-Award | Acquired | 5,839 | $2.89 |
| 26 Nov 2025 | Vieser Jaime | director | A-Award | Acquired | 5,340 | $3.16 |
| 26 Nov 2025 | Postma Robert W | director | A-Award | Acquired | 5,142 | $3.16 |
| 26 Nov 2025 | Jerman Michael Allen | director | A-Award | Acquired | 4,183 | $3.16 |